Close

Thermo Fisher Scientific Recognizes Tandem Mass Tag Grant Award Winners

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Axtria Scales Forward Deployed Engineering Team to 1,000 Experts

Global data analytics provider Axtria Inc. announced plans on...

FDA Releases Proposed Commitment Letter for Next Generic Drug User Fee Agreement

Following months of negotiations with industry stakeholders, the US...

Buying Guide: How to Source High-Quality Selank for Research

Peptide research continues to expand across academic and independent...
- Advertisement -

Thermo Fisher Scientific, the world leader in serving science, announces the winners of the 2022 Thermo Scientific Tandem Mass Tag (TMT) Research Award. Now in its eighth year, the research competition selects scientists from a pool of international applicants based on innovation and the potential impact of their work in proteomics using TMT. The proprietary TMT and TMTpro reagents are exclusively licensed to Thermo Fisher Scientific by Proteome Sciences, PLC.

Winners receive awards of TMT and other mass spectrometry-related reagents, valued at US$11,000. The scientists will use these awards to quantify, normalize and streamline global protein expression studies using mass spectrometry.

A panel of judges from Thermo Fisher and Proteome Sciences, PLC, reviewed the applications and selected the following two recipients based on the scientific merit of their proposals:

  • Stephen Holmes, University of Liverpool
    Grant Title: Inactivating and studying viruses at single-cell level
  • Dick Zijlmans, Stichting Radboud Universiteit
    Grant Title: Identifying true interactors in proximal proteome through target protein perturbation

“We are excited to offer the TMT Research Grant Award for the eighth consecutive year,” said Nicolas Pierre, senior director/general manager, cell & protein consumables, life sciences and laboratory products, Thermo Fisher Scientific. “We received a wide range of diverse submissions from graduate and postdoctoral students. We look forward to seeing what these emerging scientists achieve with our reagents and are eager to get a glimpse from them into the future of multiplex proteomics.”

Thermo Fisher Scientific is showcasing the grant award winners during the 70th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics, being held June 5-9, 2022 in Booth 400 at the Minneapolis Convention Center, Minneapolis, Minnesota and at the Hilton Minneapolis Grand Ballrooms E, F, G.

Company: Thermo Fisher Scientific


Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com

Send Enquiry for this story

By submitting this form you agree to allow www.worldpharmatoday.com to contact you regarding your enquiry.
See our Privacy Policy to learn more.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Latest stories

Related stories

Axtria Scales Forward Deployed Engineering Team to 1,000 Experts

Global data analytics provider Axtria Inc. announced plans on...

FDA Releases Proposed Commitment Letter for Next Generic Drug User Fee Agreement

Following months of negotiations with industry stakeholders, the US...

Buying Guide: How to Source High-Quality Selank for Research

Peptide research continues to expand across academic and independent...

CSPC Pharmaceutical and AstraZeneca form Biologics Joint Venture

CSPC Pharmaceutical and AstraZeneca have signed a joint venture...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »